Enzolytics Inc (ENZC)

[sspalmo]

If they did successfully transfer out their IP from the BGEN sub and ENZC has no claim to it, then in my opinion they would be better off moving forward going public by using a clean shell. I don't know which would be faster and less expensive, a legal battle with Harry for control of ENZC or finding a clean shell. They could still fight Harry to regain control of their ENZC Series A Preferred shares but in the meantime, they could be making progress towards the goals they stated previously with a clean shell. They may very well be making progress right now and just not disclosing it. I have not seen anything that stated the fate of BGEN, but I did see that CCC were removed from ENZC.

Page 22 and 23 of the latest quarterly

B. List any subsidiaries, parent company, or affiliated companies.
The Company is a 49% owner of the Bulgarian entity IMMB BG, which held a sub-license agreement issued by ENZC
for the proprietary immunotherapy treatment until it was terminated in the second quarter of 2021 and the investment
written off as worthless in the yearend 2021 financials.

The Company is 100% owner of RobustoMed, Inc.
The Company is 100% owner of BioClonetics Immunotherapy, Inc.
The Company is 100% owner of Biogenysis, Inc

https://www.otcmarkets.com/otcapi/company/financial-report/403184/content